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CASE DESCRIPTION 
A 75- year- old with left adrenal mass, hypertension and atrial fibrillation with 
elevated metanephrine and normetanephrine was diagnosed with 
pheochromocytoma. Adequate preoperative alpha blockade was established 
with oral doxazocin. General anesthesia with endotracheal tube was 
performed for laparoscopic left adrenalectomy. Perioperative blood pressure 
was closely monitored with an arterial line. Hypotension in the post-induction 
period was effectively managed with vasopressin. Hypertension during 
resection and hypotension following resection was were not encountered as 
this patient was adequately alpha- blocked preoperatively. 
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CONCLUSION  
 
Preoperatively, adequate selective alpha2 blockade with 
doxazocin minimizes hypertensive and hypotensive episodes 
during pheochromocytoma resection.3  
INTRODUCTION 
Adequate preparation with alpha 
blockade is important  in a patient 
presenting for pheochromocytoma 
resection. Use of vasopressin is 
indicated to treat intraoperative 
hypotension refractory to alpha 
agonistic agents. Clevidipine is a 
new, novel agent effective in the 
management of hypertensive 
episodes.  
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CLINICAL FEATURES: Headaches, Palpitations, Diaphoresis , Severe  Hypertension , 
Postural Hypotension, Tachyarrhythmias, Diabetes mellitus,  Pallor,  
Weight Loss, Cardiomyopathy 
PREFERRED DIAGNOSTIC TESTS 
for Pheochromocytoma (per Task 
Force of the Endocrine Society):1 
1. Plasma metanephrine: Sensitivity 96%, specificity 85% 
2. 24-hr collection of urinary catecholamines: Sensitivity 87.5%, 
specificity 99.7% 
PREOPERATIVE PREPARATION: 1. Initiate alpha blockage 10-14 days before surgery 
2. Initiate beta blockade only after complete alpha blockade 
ALPHA BLOCKERS for 
preoperative preparation:2,3 
 
1. Phenoxybenzamine:  Non-selective; prolonged half-life; causes reflex 
tachycardia; should be stopped within 24-48 hours 
2. Doxazocin:  Selective Alpha 2 antagonist; doesn’t cause reflex 
tachycardia; reduced incidence of intraop hypertension and postop 
hypotension 
PREOPERATIVE OBJECTIVES  for 
adequate  alpha  blockade:2  
 
1. Control hypertension.  2.  Reverse  circulating blood volume. 
3.  Control heart rate and arrhythmia.  4. EEG free of ST segment and T 
wave changes.  5.  Reverse hyperglycemia and electrolyte abnormalities.  
PREOPERATIVE TARGETS of 
adequate alpha blockade:2 
1. In-hospital blood pressure below 160/90 mmHg for 24 hours prior to 
surgery. 
2. No orthostatic hypotension with blood pressure <80/45 mmHg. 
3. EKG free of ST and T wave changes for one week prior to surgery. 
4. Fewer than five (5) premature ventricular contractions per minute. 
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DRUGS TO AVOID INTRAOPERATIVELY2,3 
(Laparoscopic adrenalectomy is currently the surgical method of choice) 
 Histamine releasing drugs (morphine, atracurium) 
 Vagolytic agent (pancuronium) 
 Ketamine 
CRITICAL PERIODS OF HEMODYNAMIC CHANGES DURING RESECTION2,3 
 Catecholamine surge leading to hypertensive episode:   Laryngoscopy;  
peritoneal insufflation; tumor manipulation 
 Hypotension due to catecholamine decline:  Tumor ligation 
ANESTHETIC GOALS2,3 
1.  Avoid or reduce catecholamine release due to surgical and anesthetic techniques 
2.  Avoid drugs that release catecholamines or histamines 
3.  Minimize the hypertensive response during tumor handling. 
4.  Minimize the hypotensive response following tumor resection.  
PHARMACOLOGICAL AGENTS TO CONTROL HEMODYNAMIC CHANGES 
DURING SURGERY5 
CLEVIDIPINE is effective in controlling hypertension during tumor handling. 
VASOPRESSIN is the agent of choice to treat hypotension resistant to alpha 
adrenergic agonistic agents. 
